Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.70 | €11.05 | 93.947% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €20.80 | €32.58 | 56.629% |
| Evolus Inc | 10 | 0 | 4 | 0 | €11.30 | €20.46 | 81.081% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.86 | €13.77 | 1501.512% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €193.85 | €248.57 | 28.228% |
| Chromadex Corp | 11 | 1 | 1 | 0 | €2.62 | €5.58 | 112.817% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.82 | €24.13 | 62.897% |
| Heron Therapeutics Inc. | 11 | 1 | 3 | 0 | €3.06 | €4.59 | 49.772% |
| Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | €0.59 | €4.62 | 685.217% |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | €32.60 | €56.62 | 73.672% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €353.20 | €419.64 | 18.810% |
| Geron Corp. | 12 | 0 | 2 | 0 | €2.99 | €4.63 | 54.502% |
| Corcept Therapeutics Inc. | 12 | 0 | 3 | 0 | €29.27 | €36.17 | 23.588% |
| Sangamo Therapeutics Inc. | 12 | 12 | 1 | 0 | €0.55 | €3.63 | 562.021% |
| Incyte Corp. | 12 | 2 | 2 | 0 | €52.16 | €78.42 | 50.350% |
| Verastem Inc. | 12 | 0 | 4 | 0 | €3.98 | €19.95 | 401.279% |
| MacroGenics Inc. | 13 | 0 | 4 | 0 | €4.08 | €12.42 | 204.229% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €144.35 | €184.76 | 27.994% |
| Akero Therapeutics Inc | 14 | 0 | 2 | 0 | €17.94 | €38.19 | 112.956% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €22.08 | €52.03 | 135.620% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €39.62 | €47.17 | 19.056% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €13.00 | €21.00 | 61.566% |
| Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €33.40 | €45.98 | 37.665% |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €1.97 | €8.55 | 334.775% |
| PTC Therapeutics Inc. | 15 | 8 | 3 | 3 | €33.20 | €41.51 | 25.038% |